Syros Pharmaceuticals, Inc.
SYRS
$0.032
-$0.0067-17.31%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.20% | -27.09% | -22.38% | 24.33% | -22.06% |
| Total Receivables | -- | -- | -- | -- | -5.18% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.05% | 52.82% | -28.53% | -36.81% | 25.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.72% | -24.31% | -22.61% | 18.34% | -19.73% |
|
|
|||||
| Total Current Assets | -24.72% | -24.31% | -22.61% | 18.34% | -19.73% |
| Net Property, Plant & Equipment | -3.53% | -3.37% | -3.21% | -2.98% | -12.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.63% | -2.45% | -1.13% | -28.62% | -2.18% |
| Total Assets | -20.36% | -20.79% | -19.89% | 13.79% | -18.34% |
|
|
|||||
| Total Accounts Payable | 29.15% | -34.17% | -1.72% | 304.34% | -57.34% |
| Total Accrued Expenses | 11.03% | 22.52% | -26.42% | -24.86% | 24.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.57% | -82.27% | 56.56% | 129.89% | 80.31% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -93.64% |
| Total Other Current Liabilities | -- | -- | -- | -- | -93.64% |
| Total Current Liabilities | 15.79% | -34.27% | 1.70% | 29.19% | 0.07% |
|
|
|||||
| Total Current Liabilities | 15.79% | -34.27% | 1.70% | 29.19% | 0.07% |
| Long-Term Debt | 0.36% | 37.79% | -14.03% | -12.31% | -3.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.89% | -3.66% | -3.46% | -3.22% | -2.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -66.81% | -12.61% | -43.68% | 151.53% | 31.19% |
| Total Liabilities | -15.00% | -5.51% | -21.02% | 35.89% | 3.48% |
|
|
|||||
| Common Stock & APIC | 0.22% | 0.26% | 0.28% | 6.44% | 0.47% |
| Retained Earnings | -0.85% | -3.21% | -0.51% | -9.78% | -6.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -75.11% | -142.19% | -9.63% | -54.10% | -50.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -75.11% | -142.19% | -9.63% | -54.10% | -50.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -75.11% | -142.19% | -9.63% | -54.10% | -50.43% |
|
|
|||||